Xentuzumab (Synonyms: BI 836845; Anti-Human IGF1 and IGF2 Recombinant Antibody) |
| Catalog No.GC70151 |
Xentuzumab (anticuerpo recombinante anti-IGF1 e IGF2 humano; BI836845) es un anticuerpo monoclonal humanizado dirigido a los ligandos de IGF, IGF1 e IGF2. Xentuzumab inhibe las señales de crecimiento promovidas por IGF1 e IGF2 y suprime la activación de AKT.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1417158-65-6
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Xentuzumab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Xentuzumab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *